Wonderchef turns profitable in FY24

Wonderchef, the kitchen appliance brand backed by celebrity chef Sanjeev Kapoor, has turned profitable in FY24, reporting a net profit of Rs 1.5 crore, according to data from the Registrar of Companies (RoC). It was against a total loss of Rs 51.8 crore in FY23.

Ravi Saxena, managing director of Wonderchef, told FE that the loss in FY23 was due to an “extraordinary one-time” write-off associated with the merger of a retail company into Wonderchef.

“The accommodated losses of that company merged into Wonderchef,” he said.

The company’s revenue from operations grew 20% to Rs 377.6 crore in FY24, up from Rs 315.5 crore in FY23. Total expenses increased by 16.7% to Rs 374.6 crore compared to Rs 321 crore in the previous year.

Wonderchef’s return on capital employed (ROCE) improved to 3.88% from (-)28.79% in the previous year. The Ebitda margin improved to 2% from (-)13.59%. 

Saxena attributed the consistent revenue growth to product innovation and a diverse omnichannel strategy.

For instance, it has launched a range of 14 coffee machines ranging from a French Press to automatic machines priced as high as Rs 92,000. 

“In FY24 we sold around 75,000 coffee machines in India,” Saxena said, adding that in FY25, this figure is likely to cross 100,000 units. 

Another product which has seen a high demand is its automatic cooking machine Chef Magic. Saxena said it is doing well in India as well as USA and Canada. 

The company’s focus on omnichannel strategy has helped it mitigate risks from slowdowns in specific markets or segments.

For FY25, Wonderchef expects its revenue to grow by 19.5-20%. The company is also gearing up for an IPO, which it plans to launch in the next 12-18 months. Founded in 2009 by Ravi Saxena and Sanjeev Kapoor, Wonderchef has raised approximately Rs 351.96 crore till date from investors like Sixth Sense Ventures, Amicus Capital Partners and Vervima Company.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations